Insmed Incorporated · 20 hours ago
Scientist, Biology
New Hampshire, United States
Full-time
Onsite
Mid, Senior Level
$103K/yr - $131K/yr
4+ years expInsmed Incorporated is a global biopharmaceutical company dedicated to transforming the lives of patients with serious and rare diseases. The role involves leading biological engineering projects, developing viral vectors, and executing advanced molecular biology workflows to support gene therapy programs.
BiotechnologyMedicalPharmaceutical
Responsibilities
Lead biological engineering projects focused on development of next-generation viral vectors
Create and deploy high throughput cellular and molecular screening systems to identify novel capsids
Develop and implement quantitative in vitro cellular and molecular assays to characterize lead candidates
Support viral vector projects, including transfection, transduction, viral titering, and sequencing-based characterization of viral genomes
Implement advanced molecular biology methods to design and build high diversity viral vector libraries
Design, optimize, and execute molecular biology workflows, including DNA/RNA extraction, cloning and PCR/qPCR/ddPCR
Prepare Next-Generation Sequencing (NGS) libraries (Illumina, Nanopore, PacBio) and perform quality measurements (qubit, tape station)
Perform cell culture with mammalian cell lines and primary cells
Conduct protein and nucleic acid analyses, including western blotting, ELISA, and immunoprecipitation
Document protocols, write reports, and present findings to cross-disciplinary teams
Contribute to laboratory operations, including training of junior staff and maintenance of high-quality research standards
Qualification
Required
PhD in Molecular and Cellular Biology or related field; or MS with 4+ years of hands-on research experience
Strong background in advanced molecular biology methods including cloning and recombinant DNA technologies (DNA/RNA extraction, primer/probe design, PCR/qPCR/ddPCR, Gibson Assembly, Golden Gate etc.)
Experience with viral vector engineering (large library preparation and screening)
Proficiency in NGS technologies (Illumina, Nanopore, PacBio), library preparation, and quality assessment (qubit, tape station)
Hands-on experience with viral systems, including transfection, transduction and characterization of viral genomes
Experience with mammalian cell culture including primary cells
Familiarity with protein characterization methods (western blotting, ELISA, IP) a plus
Proficiency with Python and bioinformatics pipelines preferred
Proven track record in method development, including experimental design, optimization, execution, and evaluation
Strong written and oral communication skills are required
Applicants should be detail-oriented, highly organized, and able to multi-task with multiple projects
Strong analytical and problem-solving skills a must
Preferred
Proficiency with Python and bioinformatics pipelines preferred
Familiarity with protein characterization methods (western blotting, ELISA, IP) a plus
Benefits
Comprehensive medical, dental, and vision coverage and mental health support, annual wellbeing reimbursement, and access to our Employee Assistance Program (EAP)
Generous paid time off policies, fertility and family-forming benefits, caregiver support, and flexible work schedules with purposeful in-person collaboration
401(k) plan with a competitive company match, annual equity awards, and participation in our Employee Stock Purchase Plan (ESPP), and company-paid life and disability insurance
Company Learning Institute providing access to LinkedIn Learning, skill building workshops, leadership programs, mentorship connections, and networking opportunities
Employee resource groups, service and recognition programs, and meaningful opportunities to connect, volunteer, and give back
Company
Insmed Incorporated
Insmed is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases.
1001-5000 employees
H1B Sponsorship
Insmed Incorporated has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (20)
2024 (6)
2023 (14)
2022 (8)
2021 (1)
2020 (5)
Funding
Current Stage
Public CompanyTotal Funding
$4.56BKey Investors
CureDuchenne Ventures
2025-06-11Post Ipo Equity· $750M
2024-05-30Post Ipo Equity· $650M
2023-05-08Post Ipo Equity· $0.5M
Leadership Team
Will Lewis
Chairman and Chief Executive officer
Walter R. Perkins
Chief Technology Officer
Recent News
2026-01-13
Company data provided by crunchbase